原创力文档- 1、本文档共14页，可阅读全部内容。
- 2、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
- 3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
查看更多
CLINICAL GUIDELINES
Management of cancer-associated anemia with erythropoiesis-stimulating
agents: ASCO/ASH clinical practice guideline update
Julia Bohlius,1,* Kari Bohlke,2 Roberto Castelli,3 Benjamin Djulbegovic,4 Maryam B. Lustberg,5 Massimo Martino,6 Giannis Mountzios,7
8 9 10 ` 11 12 13,
Namrata Peswani, Laura Porter, Tiffany N. Tanaka, Gianluca Trifiro, Hushan Yang, and Alejandro Lazo-Langner *
1University of Bern, Bern, Switzerland; 2American Society of Clinical Oncology, Alexandria, VA; 3University of Milan, Milan, Italy; 4City of Hope, Duarte, CA; 5Ohio State
University, Columbus, OH; 6Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria, Italy; 7Henry Dunant Hospital Center, Athens, Greece; 8Advocate Medical Group,
Orland Park, IL; 9Independent Patient Advocate, Washington, DC; 10UC San Diego Moores Cancer Center, La Jolla, CA; 11University of Messina, Messina, Italy; 12Thomas
Jefferson University, Philadelphia, PA; and 13Western University, London, ON, Canada
Purpose: To update the American Society of Clinical Oncology (ASCO)/American Society of
Hematology (ASH) recommendations for use of erythropoiesis-stimulating agents (ESAs) in patients
with cancer.
Methods: PubMed and the Cochrane Library were searched for randomized controlled trials (RCTs)
and meta-analyses of RCTs in patients with cancer published from January 31, 2010, through May 14,
2018. For biosimilar ESAs, the literature search was expanded to include meta-analyses and RCTs in
patients wi
文档评论（0）